Stay updated on Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Recruitment status now indicates enrollment is closed. The page adds new helper sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header and revision label to v3.6.0, replacing the prior heading and v3.5.5 reference.
    Difference
    0.4%
    Check dated 2026-06-15T19:59:48.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A new site revision label v3.5.5 has been added, replacing the previous v3.5.4. This update reflects a minor platform release and does not modify the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-06-08T16:38:18.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Deleted sponsor/affiliate identifiers ('Moffitt Cancer Center Clinical Trials website' and 'H. Lee Moffitt Cancer Center and Research Institute') and the 'Helpful Links Provided by' heading, changing how institutional affiliation and sponsor-related resources are presented on the study page.
    Difference
    0.1%
    Check dated 2026-06-01T12:55:25.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A new Publications entry has been added, documenting a 2026 Am J Clin Oncol article evaluating neutrophil-to-lymphocyte ratio in patients treated with cetuximab and nivolumab for recurrent/metastatic head and neck squamous cell carcinoma.
    Difference
    0.0%
    Check dated 2026-05-25T14:20:10.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a new site revision tag (Revision: v3.5.4) replacing the prior Revision: v3.5.3. This indicates a minor update to the page's template or underlying system, with no changes to the study content.
    Difference
    0.0%
    Check dated 2026-05-18T05:32:48.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The footer revision number for the ClinicalTrials.gov page is updated from v3.5.2 to v3.5.3, reflecting a site software/release update rather than a change to the trial’s study details.
    Difference
    0.0%
    Check dated 2026-04-26T15:24:22.000Z thumbnail image

Stay in the know with updates to Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.